Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil

scientific article published on August 20, 1992

Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-9149(92)91079-J
P698PubMed publication ID1510000

P50authorMaarten Jan SuttorpQ106370101
P2093author name stringJ. H. Kingma
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectAtrial FibrillationQ815819
P304page(s)56A-60A; discussion 60A-61A
P577publication date1992-08-01
1992-08-20
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleAcute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil
P478volume70

Reverse relations

cites work (P2860)
Q30469749Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
Q71596519Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone
Q72022109Benefits and Potential Risks of Atrial Antitachycardia Pacing After Repair of Congenital Heart Disease
Q28369368Dofetilide: a review of its use in atrial fibrillation and atrial flutter
Q58854950Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation
Q39438948Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation
Q28369361Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels
Q74598122Efficacy of amiodarone for the termination of persistent atrial fibrillation
Q73114389Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective
Q40612194Flecainide
Q38072091Flecainide acetate for the treatment of atrial and ventricular arrhythmias
Q51625134Flecainide is effective against premature supraventricular and ventricular contractions during general anesthesia.
Q40923068Guidelines for the use of propafenone in treating supraventricular arrhythmias
Q45054506Importance of the time of onset of supraventricular tachyarrhythmias on prognosis of patients with acute myocardial infarction
Q73028209Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators
Q71617086Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study
Q40834298Is there a future for antiarrhythmic drug therapy?
Q34523170Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
Q35057258Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation
Q44419147Pharmacodynamic Equivalence of Two Flecainide Acetate Formulations in Patients With Paroxysmal Atrial Fibrillation by QRS Analysis of Ambulatory Electrocardiogram
Q35680137Pharmacological rate control of atrial fibrillation
Q77535845Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis
Q42556863Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group
Q77213484Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study
Q32055123Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation
Q37993754Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation
Q41664554The medical management of atrial fibrillation.
Q41352642The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies
Q58716724Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
Q30471976Treatment strategies for atrial fibrillation
Q74626710[Efficacy and safety of a single oral dose of pilsicainide in supraventricular arrhythmia after coronary artery bypass grafting]

Search more.